CD4+ CD52lo T-cell expression contributes to the development of systemic lupus erythematosus
- 1 February 2018
- journal article
- research article
- Published by Elsevier in Clinical Immunology
- Vol. 187, 50-57
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Human Peripheral Blood Mononuclear Cells Exhibit Heterogeneous CD52 Expression Levels and Show Differential Sensitivity to Alemtuzumab Mediated CytolysisPLOS ONE, 2012
- Generation and expansion of regulatory human CD4+ T-cell clones specific for pancreatic islet autoantigensJournal of Autoimmunity, 2011
- Follicular Helper T Cells: Lineage and LocationImmunity, 2009
- Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseasesJournal of Dermatological Science, 2006
- Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C‐reactive proteinArthritis & Rheumatism, 2005
- A role for TARC/CCL17, a CC chemokine, in New Zealand miceRheumatology, 2005
- Clonal CD8+ and CD52– T cells are induced in responding B cell lymphoma patients treated with Campath‐1H* (anti‐CD52)European Journal of Haematology, 1997
- Emergence of CD52 −, glycosyiphosphatidylinositol-anchor deficient lymphocytes in rheumatoid arthritis patients following Campath-1H treatmentInternational Immunology, 1996
- Mechanisms of action of, and modes of resistance to, alkylating agents used in the treatment of haematological malignanciesBlood Reviews, 1992
- The 1982 revised criteria for the classification of systemic lupus erythematosusArthritis & Rheumatism, 1982